RESUMEN
INTRODUCTION: There is little information on survival rates of patients with primary biliary cholangtis (PBC) in developing countries. This is particularly true in Latin America, where the number of liver transplants performed remains extremely low for patients with advanced liver disease who fulfill criteria for liver transplantation. The goal of this study was to compare survival rate of patients with PBC in developing countries who were treated with ursodeoxycholic acid (UDCA) versus survival of patients who received other treatments (OT) without UDCA, prescribed before the UDCA era. MATERIAL AND METHODS: A retrospective study was performed, including records of 78 patients with PBC in the liver unit in a third level referral hospital in Mexico City. Patients were followed for five years from initial diagnosis until death related to liver disease or to the end of the study. Patients received UDCA (15 mg/kg/per day) (n = 41) or OT (n = 37) before introduction of UDCA in Mexico. RESULTS: Response to treatment was higher in the group that received UDCA. In the five years of follow-up, survival rates were significantly higher in the UDCA group than in the OT group. The hazard ratio of death was higher in the OT group vs. UDCA group, HR 8.78 (95% CI, 2.52-30.61); Mayo Risk Score and gender were independently associated with the risk of death. CONCLUSIONS: The study confirms that the use of UDCA in countries with a limited liver transplant program increases survival in comparison to other treatments used before the introduction of UDCA.
Asunto(s)
Colagogos y Coleréticos/uso terapéutico , Colangitis/tratamiento farmacológico , Accesibilidad a los Servicios de Salud , Cirrosis Hepática Biliar/tratamiento farmacológico , Trasplante de Hígado , Donantes de Tejidos/provisión & distribución , Ácido Ursodesoxicólico/uso terapéutico , Adulto , Colangitis/diagnóstico , Colangitis/mortalidad , Femenino , Humanos , Estimación de Kaplan-Meier , Cirrosis Hepática Biliar/diagnóstico , Cirrosis Hepática Biliar/mortalidad , Masculino , México , Persona de Mediana Edad , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia , Factores de Tiempo , Resultado del TratamientoRESUMEN
Minimal hepatic encephalopathy (MHE) corresponds to the earliest stage of hepatic encephalopathy (HE). MHE does not present clinically detectable neurological-psychiatric abnormalities but is characterized by imperceptible neurocognitive alterations detected during routine clinical examination via neuropsychological or psychometrical tests. MHE may affect daily activities and reduce job performance and quality of life. MHE can increase the risk of accidents and may develop into overt encephalopathy, worsening the prognosis of patients with liver cirrhosis. Despite a lack of consensus on the therapeutic indication, interest in finding novel strategies for prevention or reversion has led to numerous clinical trials; their results are the main objective of this review. Many studies address the treatment of MHE, which is mainly based on the strategies and previous management of overt HE. Current alternatives for the management of MHE include measures to maintain nutritional status while avoiding sarcopenia, and manipulation of intestinal microbiota with non-absorbable disaccharides such as lactulose, antibiotics such as rifaximin, and administration of different probiotics. This review analyzes the results of clinical studies that evaluated the effects of different treatments for MHE.
Asunto(s)
Encefalopatía Hepática , Encefalopatía Hepática/diagnóstico , Encefalopatía Hepática/etiología , Encefalopatía Hepática/terapia , Humanos , Lactulosa/uso terapéutico , Cirrosis Hepática/complicaciones , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/terapia , Calidad de Vida , Rifaximina/uso terapéuticoRESUMEN
Cystic tumours of the spleen are generally rare, and a parasitic origin is relatively unlikely. The present case report shows, however that when a splenic cyst is found, the differential diagnosis must always consider the possibility of echinococcosis. We report the case of a patient suffering from a cystic lesion of the spleen where surgery and histopathology yielded the diagnosis of splenic echinococcosis. Abdominal pain in the left upper quadrant and splenomegaly detected by simple abdominal radiology are the most commonly found indicators for this disease. The treatment should be surgical, attempting to preserve as much splenic tissue as possible, although conservative treatment is frequently unfeasable due to massive involvement of the spleen. Although rare, splenic hydatidosis should be included in the differential diagnosis when a cystic splenic lesion is identified with sonography or CT scan.
Asunto(s)
Equinococosis/diagnóstico , Enfermedades del Bazo/diagnóstico , Dolor Abdominal/etiología , Adulto , Quistes/diagnóstico , Diagnóstico Diferencial , Equinococosis/diagnóstico por imagen , Equinococosis/patología , Equinococosis/cirugía , Femenino , Humanos , Bazo/patología , Enfermedades del Bazo/diagnóstico por imagen , Enfermedades del Bazo/patología , Enfermedades del Bazo/cirugía , Esplenomegalia/etiología , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
BACKGROUND: Steatorrhea represents the indirect sign of lipid maldigestion in chronic pancreatitis and even when the measurement of fecal fat is considered as a gold standard for the diagnosis of steatorrhea, this test is not commonly used within clinical practice because of the inconvenience related to sample collection. Although the use of breath test using mixted tryglicerides was initally validated as an indirect alternative for the assessment of exocrine pancreas reserve, only recently has used this method as a surrogate for the measurement of fat in feces. AIM: To evaluate fat digestion by means of the breath test with 13C labelled mixed triglycerides in patients with chronic pancreatitis. MATERIAL AND METHODS: Patients with chronic pancreatitis underwent clinical and biochemical evaluation. The latter included serum amylase, lipase, betacarotenes; fecal fat analysis and breath test using 13C-mixed tryglicerides. Breath test results are expressed as the percentage of 13C recovered in the breath sample. RESULTS: Seventeen patients (age: 45 +/- 5 years) were included, of which 7 had steatorrhea (fecal fat greater than 7 g/day). In patients with steatorrhea, the percentage of recovered 13C from breath was significantly lower (6 +/- 4%) than in patients without it (25 +/- 5%). CONCLUSION: Results suggest the uselfuness of breath test with 13C-mixed tryglicerides as an alternative for the assessment of lipid digestion in patients with chronic pancreatitis.
Asunto(s)
Isótopos de Carbono , Metabolismo de los Lípidos , Pancreatitis Crónica/diagnóstico , Pancreatitis Crónica/metabolismo , Triglicéridos , Pruebas Respiratorias , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
AIM: The 13C-methacetin breath test (13C-MeBT) is a noninvasive tool that allows evaluation of the functional activity of the liver and the prediction of liver cirrhosis. Nevertheless, there is no information on its potential utility to predict long-term survival in patients with liver disease. METHODS: Patients with cirrhosis were selected. All patients underwent a complete clinical assessment, standard biochemical tests, and 13C-MeBT at the beginning of the study. Death was recorded during the three years of follow-up. Survival curves were calculated by the Kaplan-Meier method, and Cox proportional risk models were used to identify predictive factors. The ability to classify the overall risk was assessed by the C statistic. RESULTS: One hundred and twenty-three patients were included. A significant inverse correlation was found between delta over baseline at the 15 min point (DOB15) after ingestion of 13C-methacetin and the Child-Pugh score (r = -0.411, p < 0.001). In multivariate analysis, DOB15 ≤ 4.5 was associated with mortality, [HR = 2.58 95% CI (1.17-5.69)]. In conclusion, our results confirm the utility of 13C-MeBT as a simple, noninvasive tool to quantitatively assess the liver's functional reserve and as a potential predictor of long-term survival in patients with decompensated cirrhosis.
Asunto(s)
Acetamidas/química , Pruebas Respiratorias/métodos , Isótopos de Carbono/química , Cirrosis Hepática/mortalidad , Demografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Probabilidad , Modelos de Riesgos Proporcionales , Análisis de SupervivenciaRESUMEN
Intestinal lymphangiectasia is a rare autosomal dominant disorder or acquired condition that leads to lymph obstruction, poor chyle transport and concomitant problems. We describe the cases of two women with chronic diarrhea in whom the common signs of lymphagiectasia-hypoalbuminemia, lymphopenia and distal edema- were found. One of them also had pleural effusion and chylous ascites. The diagnosis was performed by intestinal biopsy. We herein review the histopathologic, radiographic and endoscopic features of this disorder and case reports in Mexican population.
Asunto(s)
Diarrea/etiología , Enfermedades Intestinales/complicaciones , Linfangiectasia Intestinal/complicaciones , Adolescente , Adulto , Enfermedad Crónica , Diarrea/diagnóstico , Diarrea/terapia , Duodenoscopía , Femenino , Humanos , Enfermedades Intestinales/patología , Enfermedades Intestinales/terapia , Mucosa Intestinal/patología , Linfangiectasia Intestinal/patología , Linfangiectasia Intestinal/terapia , Resultado del TratamientoRESUMEN
UNLABELLED: C-reactive protein (CRP) plays an important role on inflammatory processes associated to the metabolic syndrome (MS), alike of insulin sensitivity, endothelial dysfunction and fibrinolysis insufficiency. Alanine aminotransferase (ALT) may be a sensible marker for the diagnosis of hepatic damage and has therefore been used as an alternative method for the noninvasive diagnosis of non-alcoholic fatty liver disease (NAFLD), especially in epidemiological studies. At the present time, the possible utility of high sensitivity CRP (hsCRP) as a simple measure to detect the degree of hepatic inflammatory response during the development NAFLD in MS has not been explored. OBJECTIVE: To evaluate the measurement of serologic hsCRP for the identification of hepatic inflammatory response in patients with MS. MATERIAL AND METHODS: Seven hundred and forty persons (526 men and 214 women), mean age 45 +/- 11 years who were asymptomatic and otherwise seeming healthy in whom a medical questionnaire was applied underwent physical examination, laboratory testing, hepatic ultrasound and measurement of hsCRP by the immuno-turbidimetric method. Receiver operating characteristic (ROC) analysis was used to evaluate the sensitivity and specificity of all possible hsCRP for detecting different degrees of hepatic inflammation (ALT > 44 U/L and ALT > 88 U/L). Patients were stratified according to the presence of metabolic syndrome (MS) and ALT concentration in three groups: Group I, having MS and ALT > 44 U/L (n = 39); Group II, having ALT > 44 U/L without MS (n = 105) and Group III, having ALT < or = 44 U/L without MS (n = 596). RESULTS: The optimal hsCRP cut-off for detecting patients with ALT 44 U/L was 2.5 mg/L (sensibility 66%; specificity 50%) and for detecting patients with ALT > 88 U/L was 2.35 (sensibility 72%; specificity 59%). hsCRP serum concentrations in Group I were significantly higher than in Group II and Group III (p < 0.05) but no difference was found between Group II and Group III (Group I = 6.0 +/- 6.7 mg/L vs. Group II = 2.8 +/- 3.1 mg/L, vs. Group III = 2.9 +/- 4.1 mg/L). ALT concentrations were also significantly higher in Group I than in Group II and Group III, (p < 0.05) and a difference between Group II and Group III (p < 0.05) was also found (Group I = 72 +/- 31 U/L vs. Group II = 64 +/- 29 U/L vs. Group III = 24 +/- 8 U/L). CONCLUSIONS: These results suggest that the measurement of hsCRP for the identification of hepatic inflammatory response in patients with MS with NAFLD is limited because of its low sensibility and specificity observed on identifying different degrees of hepatic inflammation.
Asunto(s)
Proteína C-Reactiva/análisis , Síndrome Metabólico/sangre , Adulto , Biomarcadores , Proteína C-Reactiva/metabolismo , Hígado Graso/sangre , Hígado Graso/diagnóstico , Femenino , Humanos , Inflamación/sangre , Inflamación/diagnóstico , Hígado/metabolismo , Pruebas de Función Hepática , Masculino , Síndrome Metabólico/diagnóstico , Persona de Mediana Edad , Sensibilidad y EspecificidadRESUMEN
BACKGROUND: A total of 1,255 subjects attending a private health care facility in Mexico City were studied to evaluate the association of serum concentration of Apo A-I and Apo B with presence of gallbladder disease (gallstones or cholecystectomy). METHODS: A cross-sectional study was carried out. All participants provided data on sociodemographic status and previous diagnoses of type 2 diabetes, hypertension, cardiovascular events, alcohol consumption, and smoking habits. Women additionally reported their obstetric-gynecologic history. Weight and height were measured; liver and biliary tract ultrasound assessed gallbladder disease. Plasma levels of total cholesterol, triglycerides, high-density lipoproteins (HDL) cholesterol, and apolipoproteins A-I (Apo A-I) and B (Apo B) were determined after a 12-h fasting period. RESULTS: In multivariate models, Apo A-I > or = 120 mg/dL was positively associated with gallbladder disease with odds ratio (OR) = 1.64, 95% confidence interval (95% CI) = 1.03-2.62, whereas Apo B > or = 120 mg/dL showed an inverse association (OR = 0.71, 95% CI = 0.48-1.05). Ratio of Apo B/Apo A-I > or = 1 was inversely associated with risk of gallbladder disease (OR = 0.54, 95% CI = 0.37-0.80). All models were adjusted for age, gender, body mass index (BMI), previous diagnosis of type 2 diabetes, triglycerides, alcohol consumption, tobacco, and contraceptive use, as well as for total cholesterol in HDL-cholesterol and Apo A-I models. CONCLUSIONS: Our results suggested the relationship between serum concentration of apolipoproteins and gallbladder disease. These findings support the hypothesis of increased biliary catabolism of cholesterol in subjects with gallbladder disease characterized by lower Apo B and higher Apo A-I serum concentrations.
Asunto(s)
Apolipoproteínas A/sangre , Apolipoproteínas B/sangre , Enfermedades de la Vesícula Biliar/sangre , Adulto , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
There are several conditions that can lead to portal vein thrombosis (PVT), including including infection, malignancies, and coagulation disorders. Anew condition of interest is protein C and S deficiencies, associated with hypercoagulation and recurrent venous thromboembolism. We report the case of a non-cirrhotic 63-year-old male diagnosed with acute superior mesenteric vein thrombosis and PVT and combined deficiencies in proteins C and S, recanalized by short-term low molecular heparin plus oral warfarin therapy.
RESUMEN
BACKGROUND AND AIMS: To compare the prevalence of lactose malabsorption (LM) in children by analyzing hydrogen content in expired air vs. the inclusion of methane excretion. METHODS: A total of 138 children (4-17 years old) attending different boarding schools in Mexico were included in this study. To measure H2 and CH4 in expired air, breath samples were collected before administering whole milk (240 mL for 4- to 6-year-old children and 360 mL for 7- to 17-year-old children) and at 60, 120, 180, and 240 min afterward. A coprological examination was also carried out. RESULTS: Methane production prevalence was 47.8% (29.7% of the children produced methane and hydrogen, whereas 18.1% produced methane only). When measuring only exhaled hydrogen in expired air (H2 ≥20 ppm), prevalence of LM was 31%; however, when methane concentration was considered (H2 + (CH4 x 2)) ≥18 ppm, prevalence increased significantly to 44%. Among children with LM, 51.6% presented intestinal parasites. CONCLUSIONS: Methane should be measured in exhaled air to improve diagnosis of LM in populations with a high prevalence of methane production.
Asunto(s)
Intolerancia a la Lactosa/diagnóstico , Metano/análisis , Adolescente , Pruebas Respiratorias , Niño , Preescolar , Espiración , Heces/parasitología , Femenino , Humanos , Hidrógeno/análisis , Intolerancia a la Lactosa/epidemiología , Masculino , México/epidemiología , PrevalenciaRESUMEN
The aim of this study was to compare the oxidation of L-[1-(13)C]phenylalanine ((13)C-PheOx) in patients with chronic liver failure due to different etiologies using L-[1-(13)C]phenylalanine breath test. Breath samples were collected before the administration of 100 mg L-[1-(13)C]phenylalanine, and every 10 min thereafter until completion of 1 h. Control subjects (n=9) presented a larger cumulative percentage of (13)C dose recovery (CPDR) than patients (n=124) with chronic liver disease, regardless of the etiology (7.5+/-0.7 vs. 4.2+/-0.2, p=0.001). No differences in CPDR were found considering the Child-Pugh (CP) class or etiology: alcoholic (CP A=7.7+/-0.7, CP B=4.1+/-0.5, CP C=2.0+/-0.3), hepatitis C virus (CP A=5.4+/-0.5, CP B=4.0+/-0.2, CP C=2.2+/-0.3), hepatocellular carcinoma (CP A=5.5+/-1.6, CP B=3.6+/-1.8, CP C=2.2+/-1.0); or cryptogenic cirrhotic patients (CP A=7.4+/-1.5, CP B=4.4+/-0.4, CP C=2.1+/-0.7). Results confirm that (13)C-PheOx decreases in patients with cirrhosis with respect to controls, notwithstanding the etiology.
Asunto(s)
Pruebas Respiratorias , Isótopos de Carbono , Hepatopatías/metabolismo , Fenilalanina/análisis , Carcinoma Hepatocelular/metabolismo , Femenino , Hepatitis C/metabolismo , Humanos , Hígado/metabolismo , Cirrosis Hepática/metabolismo , Hepatopatías Alcohólicas/metabolismo , Neoplasias Hepáticas/metabolismo , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Factores de TiempoRESUMEN
BACKGROUND: One of the 2 classification criteria for fibromyalgia (FM) is the presence of tender points on specific anatomic sites. It has been established that these tender points reflect a state of generalized allodynia (defined as pain resulting from a stimulus that does not normally provoke pain). Patients with FM often describe pain elicitation during blood pressure testing (sphygmomanometry). OBJECTIVE: The objective of this study was to define if a universally used clinical test, sphygmomanometry, is helpful in the identification of patients with FM. METHODS: The authors conducted a prospective multicenter study in 3 different public rheumatology outpatient services. Each center studied 20 patients with FM, 20 with rheumatoid arthritis, 20 with osteoarthritis, and 20 healthy individuals. The following question was asked of each participant: "When I take your blood pressure, tell me if the cuff's pressure brings forth pain." The blood pressure cuff was inflated at an approximate rate of 10 mm Hg per second up to 180 mm Hg or to the point when pain was elicited. RESULTS: Sixty-nine percent of patients with FM had sphygmomanometry-evoked allodynia in contrast to 10% of patients with osteoarthritis, 5% with rheumatoid arthritis, and 2% of healthy individuals (P < 0.001). The mean blood pressure value at which allodynia was elicited was lower in patients with FM (143 +/- 40 mm Hg) when compared with the other 3 groups (176 +/- 11 mm Hg) or higher (P < 0.001). In patients with FM, there was a significant negative correlation between the blood pressure value at which allodynia developed and total Fibromyalgia Impact Questionnaire (FIQ) score, number of tender points, and the FIQ visual analog scales for pain intensity and fatigue (P < 0.05). The test yields a diagnostic sensitivity for FM of 0.7, specificity 0.96, positive predictive value 0.86, and negative predictive value 0.91. CONCLUSIONS: In this developmental study of patients attending rheumatology clinics, the generation of pain during blood pressure testing was strongly associated with the diagnosis of FM. This robust linkage probably reflects a tautologic phenomenon. A sine qua nonelement for FM diagnosis is the presence of tender points in discrete anatomic sites. These tender points in turn reflect a state of generalized mechanical allodynia that can be locally elicited by the cuff pressure during blood pressure testing. Sphygmomanometry is a simple bedside test that may be useful in the recognition of patients with FM. Blood pressure testing is a universal procedure in all clinical environments. Based on our results, we suggest searching for FM features in any person who has sphygmomanometry-evoked allodynia.
Asunto(s)
Fibromialgia/diagnóstico , Esfigmomanometros/provisión & distribución , Adulto , Lechos , Femenino , Fibromialgia/clasificación , Humanos , Masculino , Persona de Mediana Edad , Estudios Multicéntricos como Asunto , Encuestas y CuestionariosRESUMEN
La colangitis supurativa aguda es una entidad que amenaza la vida siendo la descomprensión biliar temprana, esencial para la supervivencia. Se analizó retrolectivamente la evolución de 31 pacientes (21 mujeres y 10 hombres con una edad promedio de 64 años) con colangitis supurativa aguda (CSA) a quienes se les realizó drenaje biliar (DB) endoscópico y/o esfinterotomía. Doce pacientes habían presentado cuadros previos sugestivos de colangitis en el año previo al procedimiento. La estancia hospitalaria fue de 18ñ12 días, ocurriendo cinco muertes durante la hospitalización, ninguna relacionada con la descompresión biliar, 16 pacientes tenían colecistectomía previa, 12 habían presentado colangitis en el año previo, 23 pacientes tuvieron coledocolitiasis y tres pacientes más tuvieron neoplasias pancreatobiliares y litiasis en colédoco. Sólo el 67.7 por ciento presentó la clásica triada de Charcot (fiebre, dolor abdominal e ictericia). Después del DB se observó disminución significativa en la concentración de bilirrubina total, aspartato aminotransferasa, alanino aminotransferasa y en el número total de leucocitos (p<0.05). La única complicación relacionada con el procedimiento endoscópico, fue la perforación retroperitoneal en un paciente. Estos resultados sugieren que la canulación endoscópica es un procedimiento seguro y efectivo para la descompresión biliar de emergencia para el tratamiento de la colangitis supurativa aguda
Asunto(s)
Adulto , Persona de Mediana Edad , Humanos , Masculino , Femenino , Conductos Biliares/fisiopatología , Colangiografía , Colangitis/terapia , Drenaje de Agua , Endoscopía/estadística & datos numéricos , Esfinterotomía Endoscópica , Interpretación Estadística de DatosRESUMEN
Se informa el caso de una mujer con cirrosis biliar primaria asociada a mieloma múltiple e hipotiroidismo. La biopsia hepática mostró daño histológico estadio II-III de la clasificación de Scheuer. El mieloma múltiple era estadio II-A y correspondió al tipo IgG-lambda. Se han informado otros tres casos adicionales en la literatura que presentaron cirrosis biliar primaria asociada a mieloma múltiple. Como grupo, los cuatro casos han cursado con daño hepatico leve moderado, con lesiones óseas extensas; en tres el mieloma múltiple ha sido del tipo IgG-lambda. Aunque esta asociación puede ser sólo incidental, existen evidencias que hacen sospechar una relación patológica entre estas enfermedades: este reporte resume esta información
Asunto(s)
Humanos , Femenino , Hipotiroidismo , Inmunoglobulina G , Cirrosis Hepática Biliar , Mieloma MúltipleRESUMEN
Background. The association between gallstone disease (gallstones or cholecystectomy) and plasma lipids was evaluated in 2,089 subject who attended a private health care facility in Mexico city from august 1991 to August 1992. Methods. All participants provided data on their sociodemographic status, non-insulin dependent diabetes mellitus diagnoses, alcohol consumption, and smoking habits; women also gave data regarding their obstetric-gynecologic histories. Ultrasounds of the liver and biliary tract were performed. Cholesterol levels, high-density lipoproteins cholesterol, and triglyceride plasma concentration were determined. Results. This study shows a strong inverse association between gallstone disease and plasma cholesterol concentration, with OR = 0.61 (95 percent CI = 0.42-0.89) in the category of 181-239 mg/dL, and OR = 0.49 (95 percent CI 0.32-0.77) in the group of 240 mg/dL or more, when compared to 180 mg/dL or less, after adjusting for the following risk factors; gender, age, and body mass index. Conclusions. These results suggest an increment in the catabolic pool of cholesterol, reflected in lower levels of plasm cholesterol in subjects with gallstone disease
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Colelitiasis/sangre , Colesterol/sangre , Colecistectomía , Estudios RetrospectivosRESUMEN
La dieta al poder ser manipulable puede de una u otra forma comprometer la función del hígado o contribuir para mantener la misma a niveles óptimos. El objetivo del presente trabajo fue revisar los recientes avances del efecto de la nutrición sobre los aspectos clínicos en enfermedades hepáticas crónicas y el uso adecuado de medidas dietéticas haciendo énfasis en los estudios que al respecto se han realizado en México. Se incluyeron informes originales en inglés y español a través de información computada (Medline) hasta 1994, además de los informes publicados en revistas nacionales sobre el aspecto nutricio en enfermedades hepáticas
Asunto(s)
Humanos , Enfermedad Crónica , Metabolismo Energético , Hepatopatías/dietoterapia , Hepatopatías/metabolismo , Minerales/administración & dosificación , Ciencias de la Nutrición , Necesidades Nutricionales , Desnutrición Proteico-Calórica/etiología , Vitaminas/administración & dosificaciónRESUMEN
El síndrome de úlcera rectal solitaria (SURS), es una entidad poco frecuente en nuestro medio. Su origen, historia natural y tratamiento son aún inciertos. Se informa el caso de siete pacientes con las características clínicas, histopatológicas y endoscópicas del síndrome atendidos en el Instituto Nacional de la Nutrición entre 1980 y 1992. Los síntomas más frecuentes fueron: hemorragia rectal, dolor abdominal, pujo, tenesmo recta y moco en heces. Los exámenes de laboratorio fueron inespecíficos. En el 85.7 por ciento se encontró una o más úlceras. La distancia promedio de la lesión desde la margen anal fue de 5.2 cm., y ésta se encontró en la pared rectal anterior. El tratamiento médico quirúrgico fue satisfactorio.